Musclin is an activity-stimulated myokine that enhances physical endurance E Subbotina, A Sierra, Z Zhu, Z Gao, SRK Koganti, S Reyes, E Stepniak, ... Proceedings of the National Academy of Sciences 112 (52), 16042-16047, 2015 | 171 | 2015 |
2-Methoxyestradiol binding of GPR30 down-regulates angiotensin AT1 receptor S Koganti, R Snyder, U Gumaste, VT Karamyan, T Thekkumkara European journal of pharmacology 723, 131-140, 2014 | 51 | 2014 |
Sarcolemmal ATP-sensitive potassium channels modulate skeletal muscle function under low-intensity workloads Z Zhu, A Sierra, CML Burnett, B Chen, E Subbotina, SRK Koganti, Z Gao, ... Journal of General Physiology 143 (1), 119-134, 2014 | 43 | 2014 |
Pharmacologic effects of 2-methoxyestradiol on angiotensin type 1 receptor down-regulation in rat liver epithelial and aortic smooth muscle cells S Koganti, R Snyder, T Thekkumkara Gender medicine 9 (2), 76-93, 2012 | 24 | 2012 |
Loss of ATP-Sensitive Potassium Channel Surface Expression in Heart Failure Underlies Dysregulation of Action Potential Duration and Myocardial Vulnerability to Injury HZDM Gao Z, Sierra A, Zhu Z, Koganti SR, Subbotina E, Maheshwari A, Anderson ... PLoS One, 2016 | 14 | 2016 |
Disruption of ATP-sensitive potassium channel function in skeletal muscles promotes production and secretion of musclin A Sierra, E Subbotina, Z Zhu, Z Gao, SRK Koganti, WA Coetzee, ... Biochemical and biophysical research communications 471 (1), 129-134, 2016 | 13 | 2016 |
Morpholino-driven gene editing: a new horizon for disease treatment and prevention E Subbotina, SRK Koganti, D Hodgson-Zingman, LV Zingman Clinical pharmacology and therapeutics 99 (1), 21, 2016 | 13 | 2016 |
Disruption of KATP channel expression in skeletal muscle by targeted oligonucleotide delivery promotes activity-linked thermogenesis SRK Koganti, Z Zhu, E Subbotina, Z Gao, A Sierra, M Proenza, L Yang, ... Molecular therapy 23 (4), 707-716, 2015 | 12 | 2015 |
Cardioprotective role of G-protein coupled estrogen receptor 1 (GPER1) S Koganti Molecular Membrane Biology 32 (2), 35-38, 2015 | 6 | 2015 |
TANNIC ACID AN INHIBITOR FOR ANGIOTENSIN TYPE 1 RECEPTOR AND HYPERTENSION IN SPONTANEOUSLY HYPERTENSIVE RATS U Gumaste, R Snyder, S Koganti, V Karamyan, T Thekkumkara The FASEB Journal 25, lb486-lb486, 2011 | 1 | 2011 |
Allosteric Modulation of Neuronal Nicotinic Acetylcholine Receptors MM Levandoski, S Koganti | | 2016 |
Musclin‐a Novel Exercise Factor E Subbotina, A Sierra, Z Zhu, Z Gao, S Koganti, E Stepniak, ... The FASEB Journal 30, 1014.6-1014.6, 2016 | | 2016 |
Uncharged stereoregular nucleic acid analogs: 2. Morpholino nucleoside oligomers with carbamate internucleoside linkages E Subbotina, SRK Koganti, DM Hodgson-Zingman, LV Zingman Clinical Pharmacology and Therapeutics 99 (1), 21-25, 2016 | | 2016 |
Author's Accepted Manuscript S Koganti, U Russell Snyder | | 2013 |
2-Methoxyestradiol, a novel pharmacological inhibitor for Angiotensin Type I Receptor S Koganti | | 2012 |
2‐Methoxy Estradiol Mediated Downregulation of Angiotensin Type 1 Receptor Expression S Koganti, T Thekkumkara The FASEB Journal 24, 786.13-786.13, 2010 | | 2010 |
Disruption of KATP channel expression in skeletal muscle by targeted oligonucleotide delivery promotes activity-linked thermogenesis. SR Koganti, Z Zhu, E Subbotina, Z Gao, A Sierra, M Proenza, L Yang, ... | | |